Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about ALPMY
Recent news which mentions ALPMY
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
NUVB
Contracts
DSKYF
From
Benzinga
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
June 27, 2022
Tickers
ALPMF
ALPMY
Tags
ALPMY
Biotech
Market News
From
Benzinga
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
May 09, 2022
Tickers
ALPMF
ALPMY
TWST
Tags
ALPMY
Trading Ideas
Small Cap
From
Benzinga
Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer
April 13, 2022
Tickers
ALPMF
ALPMY
SGEN
Tags
ALPMY
SGEN
European Medicines Agency
From
Benzinga
Astellas' Menopause Drug Suffers Setback After Failed Asian Trial
March 15, 2022
Tickers
ALPMF
ALPMY
Tags
Phase 3 Trial
General
Briefs
From
Benzinga
Got $1,000? Here's a Dirt-Cheap Big Pharma Stock to Buy
March 15, 2022
Tickers
ALPMY
BMY
BNTX
JNJ
Tags
Recent Press Releases
Market News
PFE
From
Motley Fool
Astellas Touts Safety Data For Phase 3 Menopause Drug, Sets Up US Filing
March 07, 2022
Tickers
ALPMF
ALPMY
Tags
Briefs
News
ALPMF
From
Benzinga
Astellas Pharma - Seagen's Enfortumab Shows 36% Pathologic Complete Response In Bladder Cancer Patients
February 15, 2022
Tickers
ALPMF
ALPMY
SGEN
Tags
SGEN
ALPMY
Market News
From
Benzinga
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
Tickers
ADAP
AGEN
ALPMY
GSK
Tags
GSK
Market News
Recent Press Releases
From
Motley Fool
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
December 02, 2021
Tickers
ALPMF
ALPMY
NVS
RHHBF
Tags
ALPMY
NVS
Trading Ideas
From
Benzinga
Astellas Pharma's Bladder Cancer Treatment Scores Approval In Japan
September 27, 2021
Tickers
ALPMF
ALPMY
Tags
Biotech
Market News
ALPMY
From
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Tickers
ABT
ACAD
ADGI
ALPMY
Tags
INZY
MTEM
NAUT
From
Benzinga
Astellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical Hold
September 14, 2021
Tickers
ALPMF
ALPMY
Tags
Health Care
gene therapy
General
From
Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
Tickers
ACIU
ADGI
ALKS
ALPMY
Tags
ZNTL
Offerings
DRMA
From
Benzinga
See Why Astellas Stopped Dosing In Neuromuscular Disease Gene Therapy Trial
September 01, 2021
Tickers
ALM
ALPMF
ALPMY
Tags
ALM
Health Care
gene therapy
From
Benzinga
After FDA Rejection, EMA Approves FibroGen-Astellas' Roxadustat
August 20, 2021
Tickers
AKBA
ALPMF
ALPMY
AZN
Tags
FGEN
Health Care
Benzinga
From
Benzinga
Here's What Recent News From the FDA Means for AstraZeneca
August 20, 2021
Tickers
ALPMY
AZN
FGEN
Tags
Market News
AZN
ALPMY
From
Motley Fool
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Tickers
ABVC
ACAD
ACET
ADMA
Tags
AVRO
INM
ACAD
From
Benzinga
FibroGen Shares Are Trading Lower As FDA Shoots Down Roxadustat Application, Asks For Additional Trial
August 11, 2021
Tickers
ALPMF
ALPMY
AZN
FGEN
Tags
ALPMY
Trading Ideas
Anemia
From
Benzinga
Why Investors Should Like BioNTech's Latest Deal With Gilead
July 31, 2021
Tickers
ALPMY
BNTX
GILD
PFE
Tags
ALPMY
BNTX
Market News
From
Motley Fool
The IPO Recap – Party Is Everything But Over
July 28, 2021
Tickers
ABSI
ALPMY
BASE
CNM
Tags
Benzinga
CRBU
GAMB
From
Benzinga
Astellas - Seagen's PADCEV Wins Full FDA Approval And Expanded Label In Tough-To-Treat Urothelial Cancer
July 12, 2021
Tickers
ALPMF
ALPMY
SGEN
Tags
Biotech
Market News
SGEN
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.